HeartLung.AI will be the only company at ESC Congress 2026 presenting this high number of accepted scientific studies. The achievement reflects the strength of the company’s research program and the ...
For the past two years, healthcare has been saturated with AI promises, from predictive diagnostics to drug discovery. But 2026 is different: the industry is now witnessing the first concrete outcomes ...
In 2026, AI made decisive gains in healthcare, from FDA-cleared diagnostic tools with 94% accuracy to the first fully AI-designed drug showing positive Phase IIa results. Hospitals also deployed AI ...